[{"NetIncomeLossConverted_1_Q3_USD":110428000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":133854419.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":133318979.0,"RevenuesConverted_3_Q3_USD":282668000.0,"RevenuesConverted_1_Q3_USD":103616000.0,"CommonStockSharesConverted_0_Q3_shares":130826122.0,"Assets_0_Q3_USD":1210213000.0,"EarningsPerShareBasic_1_Q3_USD":0.85,"StockholdersEquity_0_Q3_USD":876274000.0,"EarningsPerShareDiluted_1_Q3_USD":0.82,"EarningsPerShareDiluted_3_Q3_USD":0.02,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-55284000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":129520837.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":130665831.0,"NetIncomeLossConverted_3_Q3_USD":3330000.0,"CommonStockSharesOutstanding_0_Q3_shares":130826122.0,"EarningsPerShareBasic_3_Q3_USD":0.03,"Ticker":"VIR","CIK":"1706431","name":"VIR BIOTECHNOLOGY, INC.","OfficialName":"Vir Biotechnology Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3076942595.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]